GENEVA–(BUSINESS WIRE)–Alcon to participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
Category: Business
Eyenuk Will Announce Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System at ARVO Conference
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc. will release data from a pivotal clinical trial on EyeArt AI Eye Screening at ARVO in Vancouver, BC.
EnChroma Glasses Enhance O’Keeffe Museum Experience for Color Blind Visitors
SANTA FE, N.M. & BERKELEY, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/colorishere?src=hash" target="_blank"gt;#colorisherelt;/agt;–The Georgia O’Keeffe Museum and EnChroma® are partners on a…
Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting.
Ocular Therapeutix™ to Present New Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting and at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
Alcon to Host Trading Update for First Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Host Trading Update for First Quarter 2019 Results on Thursday, May 16, at 3:00 p.m. Central European Time/8 a.m. CDT
Alcon to Host Trading Update for First Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Host Trading Update for First Quarter 2019 Results on Thursday, May 16, at 3:00 p.m. Central European Time/8 a.m. CDT
Global Ophthalmology Therapeutics Market 2019-2023 – Key Players are Allergan, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, and Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The ophthalmology therapeutics market will register a CAGR of nearly 6% by 2023. The new drug approvals and strong drug pipeline will trigger the ophthalmology therapeutics market growth in the forthcoming years. Top players in the market are focusing on the development of disease-modifying drugs for treating the rising incidences of eye diseases. Further
Aura Biosciences to Present Two Year Phase 1b/2 Clinical Data for AU-011 at the Association for Research in Vision and Ophthalmology (ARVO) 2019 Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that two year clinical data from its ongoing Phase 1b/2 clinical trial evaluating the safety and efficacy o…
Visioneering Technologies, Inc. and Lambda-X Develop Software to Show Accurate Power Profile of NaturalVue Multifocal Contact Lenses
ATLANTA–(BUSINESS WIRE)–US-based medical device company and inventor of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX: VTI) (‘VTI’ or ‘The Company’) has released additional data regarding its paten…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Analysis on the $1.35 Billion Ophthalmic Lasers Market, 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Lasers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic lasers market was worth US$ 1,069 Million in 2018. Looking forward, the market is projected to reach a value of US$ 1,353 Million by 2024, registering a CAGR of around 4% during 2019-2024. The rising demand for economical, harmless and pain-free ophthalmic laser therapies coupled
Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases
NEW YORK–(BUSINESS WIRE)–Ophthotech announced today that the Company has converted its option and entered into an exclusive global license agreement with UPenn.
The Global Electroretinography Market 2019-2027 by Product, Application and Geography – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Electroretinography Market to 2027 – Global Analysis and Forecasts By Product, Application, and Geography” report has been added to ResearchAndMarkets.com’s offering. The global electroretinography market is expected to reach US$ 62.72 Mn in 2027 from US$ 35.79 Mn in 2018. The electroretinography market is estimated to grow with a CAGR of 6.7% from 2019-2027. The market is driven by the factors such as, are rising prevalence of glaucoma among individuals, increasin
Eyenuk, Inc. Combines Artificial Intelligence Disease Detection with Human Grading to Launch the EyeScreen™ Human + AI Diagnostic Service
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc., announced today the launch of the EyeScreen™ Human + AI Diagnostic Service for diabetic retinopathy.
Eye Health America Announces Newest Acquisition of Carolinas Centers for Sight
ATLANTA–(BUSINESS WIRE)–Eye Health America (EHA), a leader in eye care practice management, announced today the acquisition of Carolinas Centers for Sight, the company’s second acquisition of 2019. Based in Florence, S.C., Carolinas Centers for Sight…
愛爾康以獨立上市公司型態亮相
日內瓦–(BUSINESS WIRE)–(美國商業資訊)–致力於幫助人們擁有明亮雙眸的全球眼科保健領導者愛爾康(Alcon)今天宣佈以獨立上市公司型態亮相，並完成從諾華(Novartis)的拆分。該公司股票於今日起在瑞士證券交易所(SIX Swiss Exchange)和紐約證券交易所(NYSE)上市交易，交易代碼為“ALC”。 愛爾康是全球最大的眼科保健器材公司，其手術產品和視力保健產品業務相輔相成。該公司業務遍及全球74個國家，為140多個國家的病患服務，在新興市場的業務快速成長。愛爾康擁…
Allegro Ophthalmics Appoints Marc Carlson and Rebecca Colbert to the Company’s Board of Directors
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DME?src=hash" target="_blank"gt;#DMElt;/agt;–Allegro Ophthalmics, LLC today announced that Marc Carlson and Rebecca Colbert have b…
Samenvatting: Alcon debuteert als onafhankelijke, beursgenoteerde onderneming
GENEVA–(BUSINESS WIRE)–Alcon, wereldleider in oogzorg die mensen op briljante wijze helpt te zien, heeft vandaag haar debuut als een onafhankelijk, beursgenoteerd bedrijf en de voltooiing van de scheiding van Novartis aangekondigd. De aandelen van he…
Riassunto: Alcon debutta come società indipendente quotata in borsa
GINEVRA–(BUSINESS WIRE)–Alcon, società leader a livello globale nel settore oftalmico dedita ad aiutare le persone a vedere al meglio, ha annunciato oggi il proprio debutto come società indipendente quotata in borsa e il completamento del processo di…